Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -13.888% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a: COC(=O)c1ccc(NC(=O)COC(=O)c2nc3nccc(C)n3n2)cc1
b: COc1ccc(N2CCN(/C(=N\S(=O)(=O)c3ccc(C)cc3)Nc3nc(C)cc(C)n3)CC2)cc1
Answer: a. COC(=O)c1ccc(NC(=O)COC(=O)c2nc3nccc(C)n3n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COC(=O)c1ccc(NC(=O)COC(=O)c2nc3nccc(C)n3n2)cc1
COC(=O)c1ccc(NC(=O)COC(=O)c2nc3nccc(C)n3n2)cc1
[2-(4-methoxycarbonylanilino)-2-oxoethyl] 7-methyl-[1,2,4]triazolo[1,5-a]pyrimidine-2-carboxylate